| 13.48 Real-Time Quote |  -0.01 / -0.07%Today’s Change | 10.01 Today|||52-Week Range 19.67 | +21.66% Year-to-Date |
| Previous close | 13.49 |
| Today’s open | 13.44 |
| Day’s range | 13.42 - 13.48 |
| Volume | 544,756 |
| Average volume (3 months) | 971,134 |
| Market cap | $1.5B |
| Dividend yield | -- |
| Earnings growth (last year) | -4.62% |
| Earnings growth (this year) | -299.49% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +128.09% |
| P/E ratio | NM |
| Price/Sales | 7.85 |
| Price/Book | 10.09 |
| Today’s change | Today’s % change | |
|---|---|---|
| WXWuXi Pharmatech (Cay... | 0.00 | 0.00% |
| SNTSSantarus Inc | +0.28 | +1.26% |
| AKRXAkorn Inc | 0.00 | 0.00% |
| MNKDMannkind Corp | 0.00 | 0.00% |
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | -$0.68 |
| Annual revenue (last year) | $150.2M |
| Annual profit (last year) | -$72.6M |
| Net profit margin | -48.34% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Director Peter M. Hecht, PhD |
Senior VP, Chief Operating & Financial Officer Michael J. Higgins, MBA |
Corporate headquarters Cambridge, Massachusetts |
.
